Neurobiology of AgingNeurosciencePeer-reviewed journal article
Aβ toxicity rescued by protein retention in the ER
James H. CattersoniD, Lucy J. MinkleyiD, Salomé Aspe, Sebastian Judd-MoleiD, Sofia MouraiD, Miranda C. DysoniD, Arjunan Rajasingam, Nathaniel S. WoodlingiD, Magda Luciana AtilanoiD, Mumtaz Ahmad, Claire S. DurrantiD, Tara L. Spires‐JonesiD, Linda PartridgeiD
Abstract
Accumulation of A{beta} in the brain is one of the hallmarks of Alzheimers disease (AD). In the adult Drosophila brain, human A{beta} over-expression is toxic and leads to deterioration of climbing ability and shortened lifespan. However, it remains unknown if A{beta} is inherently toxic or if it triggers toxic downstream pathways that lead to neurodegeneration. Here, we describe a novel, and previously unidentified, protective role of intracellular laminin chain accumulation. Despite high A{beta} levels, over-expression of the extracellular matrix protein subunit Laminin B1 (LanB1) resulted in a robust rescue of toxicity, highlighting a potential protective mechanism of resistance to A{beta}. Over-expression of other Laminin subunits and a Collagen IV subunit also significantly rescued A{beta} toxicity, while combining LanB1 with these subunits led to an even larger rescue. Imaging revealed that LanB1 was retained in the ER but had no effect on the secretion of A{beta} into the extracellular milieu. LanB1 rescued toxicity independently of the IRE1/XBP1-mediated branch of the ER stress response. Interestingly, over-expression of ER-targeted GFP also rescued A{beta} toxicity, indicating a potentially broader benefit of ER protein retention. Finally, in proof-of-principle lentiviral transduction experiments using murine organotypic hippocampal slice cultures, over-expression of mouse Lamb1 resulted in ER-retention in transduced cells, highlighting a conserved mechanism. Typically, retention of proteins in the ER is detrimental to cellular health, but in the context of neuronal A{beta} toxicity it may prove to be beneficial and a new therapeutic avenue for AD.
- organism: Drosophila
- organism: mouse
- assay: protein structure
- assay: proteomics
- research focus: drug response / drug discovery
- research focus: protein design
- approach: experimental assay
- Citations
- 9
- FWCI
- 1.59
- Field percentile
- top 18%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neuronal expression of S100B triggered by oligomeric Aβ peptide protects against cytoskeletal damage and synaptic loss
Joana Saavedra, Mariana Nascimento, … Isabel Cardoso·bioRxiv·Apr 4, 2025
- Intraneuronal binding of amyloid beta with reelin -implications for the onset of Alzheimer's disease
Asgeir Kobro‐Flatmoen, Stig William Omholt·PLoS Computational BiologyPeer-reviewed·Jan 7, 2025
- Manipulation of neuronal activity in the entorhinal-hippocampal circuit affects intraneuronal amyloid-β levels
Christiana Bjorkli, Nora Cecilie Ebbesen, … Ioanna Sandvig·bioRxiv·Jul 5, 2022
- Dicer1 promotes Aβ clearance via blocking B2 RNA-mediated repression of apolipoprotein E
Yan Wang, Meiling Lian, … Shengzhou Wu·Biochimica et Biophysica Acta (BBA) - Molecular Basis of DiseasePeer-reviewed·Dec 4, 2020
- Essential conserved neuronal motors kinesin-1 and kinesin-3 regulate Abeta42 toxicity in vivo
Deepthy Francis, Francesco Paonessa, … Isabel M. Palacios·Open BiologyPeer-reviewed·May 13, 2026
- Amyloid β Induces Hormetic-Like Effects Through Major Stress Pathways in a C. elegans Model of Alzheimer's Disease
James D. Lichty, Hrishikesh Mane, … Adriana San‐Miguel·PLoS ONEPeer-reviewed·Apr 24, 2025